Skip to content
OpenCapital
Get started

Bio-Rad Laboratories BIO Q3 2025 earnings

Reported October 29, 2025 · After market close

Revenue$653.0MMiss by $41.6M
EPS$2.26Miss by $0.04
Revenue estimate$694.6M
EPS estimate$2.30

Next report

Aug 4, 2026 (In 6 days)
Revenue estimate$624.0M
EPS estimate$1.75

Financials

Q3 2025

Income statement

See full
Revenue$653.0M+0.5%
Gross profit$343.4M-3.5%
Operating income$65.3M+1.2%
Net income-$341.9M-152%
EPS (diluted)-$12.70-154%

Balance sheet

See full
Cash & equivalents$398.2M-3.4%
Total debt$1.4B+0.5%
Total equity$6.7B-10.0%
Total assets$9.7B-8.6%

Cash flow

See full
Operating cash flow$120.9M-26.1%
CapEx$31.7M-21.1%
Free cash flow$89.2M-27.7%

Valuation & ratios

Valuation

as of 09/30/25
See full
Market cap$7.59B-18.6%
Enterprise value$8.59B-16.6%
P/S3×-0.6×

Profitability

See full
Gross margin52.3%-2.1pp
Operating margin8.8%-3.1pp
Net margin-26.4%-2.9pp
FCF margin13.2%+3.6pp

Returns & leverage

See full
Return on equity-9.5%-0.3pp
Debt / equity0.2×0.0×
Current ratio5.4×-0.7×

Segments

By segment

See full
Clinical Diagnostics$391.2M+0.6%
Life Science$261.8M+0.3%
All Other Segments--100%

By geography

See full
Europe$222.2M+8.0%
Asia Pacific$121.0M-4.6%
Americas$39.8M-2.7%

Versus estimates

Revenue

Q1 2026$592.1MBeat by $2.2MQ4 2025$693.2MBeat by $4.4M
Q3 2025$653.0MMiss by $41.6M
Q2 2025$651.6MBeat by $17.8MQ1 2025$585.4MBeat by $12.2MQ4 2024$667.5MMiss by $12.3M

Diluted EPS

Q1 2026$1.89Miss by $0.10Q4 2025$2.51Miss by $0.06
Q3 2025$2.26Miss by $0.04
Q2 2025$2.61Beat by $0.68Q1 2025$2.54Beat by $0.81Q4 2024$2.90Beat by $0.04

Ask the moment Bio-Rad Laboratories reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Bio-Rad Laboratories report Q3 2025 earnings?
Bio-Rad Laboratories (BIO) reported Q3 2025 earnings on October 29, 2025 after market close.
What were Bio-Rad Laboratories's Q3 2025 revenue and EPS?
Bio-Rad Laboratories reported revenue of $653.0M and eps of $2.26 for Q3 2025.
Did Bio-Rad Laboratories beat estimates in Q3 2025?
Revenue missed the consensus estimate of $694.6M by $41.6M. EPS missed the consensus estimate of $2.30 by $0.04.
How did Bio-Rad Laboratories's Q3 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 0.5% from $649.7M a year earlier and eps grew 12.4% from $2.01.
Where can I find Bio-Rad Laboratories's Q3 2025 SEC filings?
You can read the 10-Q periodic report (0000012208-25-000077) directly on SEC EDGAR. The filing index links above go to sec.gov.